Girish Malhotra discusses the FDA's Rule 21CFR314.70, and whether it is a case of “shackled freedom” for pharmaceutical manufacturing.
At the 2015 Annual ISPE Meeting, experts discussed data integrity trends from a regulatory and...
At the ISPE Annual Meeting, one presentation gathered a panel of experts from a variety of...
New digital tools emerge to offer manufacturers another option for data management.
The summer of 2014 brought with it the like we haven't seen in years: the outbreak of a deadly virus. Since that time, experts have immersed themselves in the creation of a vaccine for Ebola and outbreak preparation.
A press release reported that Biogen plans to cut about 11 percent of its workforce for the purpose of "refocusing its research on treatments for Alzheimer's disease and multiple sclerosis"—an update that I found rather contradictory, given the entirety of several press releases on the matter.
Meg Snyder, the new Editor of Pharmaceutical Processing, divulges some of the behind the scenes information about the October 2015 edition: biosimilars, botanicals, and more.
On the second and final day of Systech’s 2015 Uniquity Global Conference, speakers delved into topics such as global counterfeiting, company safety, and consumer safety.
The first day of the 2015 Uniquity conference concludes, but not without giving attendees much to ponder on regarding serialization.
Two of the FDA's experts discuss the FDA's recent publishing of the final rule implementing section 708 of the FDASIA.
Meg Snyder joins the Pharmaceutical Processing team as Editor.
The global flexible packaging segment of pharmaceuticals is projected to be worth over $11 billion by 2019.
Some estimates point to biologics as making up more than 60 percent of the drugs currently in clinical development and predict that 50 percent of all pharmaceuticals will be biologics by 2020.
What started out as a bad case of the flu 14 years ago became a journey of more than 100 emergency room visits and hospital re-admissions, countless lab tests and numerous specialists. I became a case study of what happens when lack of patient engagement meets up with uncoordinated care.
It’s an undeniable fact that at some stage in your existence, you’re going to want to change and upgrade something about your life. Whether it’s your car or your partner, it’s rarely a simple procedure and the idea of change can be a little scary sometimes.
A recent study, published in the British medical journal The Lancet, reported a 45 percent rise in the prevalence of diabetes worldwide from 1990 to 2013. The majority the rise was in Type 2 Diabetes, the most common form of the disease ...
I went into medicine for one reason: I wanted to help people. And five years ago, my practice was fortunate enough to embark on a transformation that helped us provide our patients with greater access to higher quality care.
So it turns out recreational marijuana users are more diverse than your average Grateful Dead fan. According to a recent Forbes expose, pot aficionados in Seattle include everyone from curious tourists to medicinal marijuana patients and baby boomers hoping to recapture their youth.